Rachel Esther Myasthenia Gravis Foundation Inc
The Rachel Esther Mysasthenia Gravis Foundation has been established to educate, empower, and enrich the lives of teenagers diagnosed with the Mysasthenia Gravis through public education and grants for the benefit of teens and through grants to MG researchers.
ICO
271259593
Web
Sign in to see organisation website
Address
From Social media
News about from their social media (Facebook and X).
Data about organisation
Join us and make a difference for the future!
Finally, a clear and organized way to explore local and global charities.
Yvette
As a teacher, I use Eduo in class to show students how civic engagement works. It’s inspiring and educational. Highly recommend for schools and community groups.
Stacy
Transparent, useful, and beautifully designed.
Yvette
Eduo.org helped me discover a small local organization doing amazing environmental work that I would’ve never found otherwise. It’s a hidden gem for socially conscious people.
Eve
I stumbled on Eduo by accident and ended up spending hours learning about different charities across the world. It’s like a global map of goodness
Yvette
Clean, community-driven, and full of heart — love it.
Kira
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Ivca
2025-10-27
"Exciting to see progressive leaders like Zohran Mamdani gaining momentum in the mayoral race with support from Bernie Sanders and AOC—hope this inspires similar movements in our communities! 🌟 #PositiveChange"
New York mayoral candidate Zohran Mamdani rallies voters with support from Bernie Sanders and AOC
stamford advocate
Like Comment
Anna
2025-10-27
🌟 Exciting news for heart health! Medtronic's SPYRAL HTN-ON MED trial shows that their RDN procedure leads to lasting blood pressure reductions over three years. Innovative healthcare solutions are paving the way for healthier lives! 💙 #HealthcareInnovation #PositiveNews
Medtronic's RDN Procedure Shows Lasting Blood Pressure Reductions In 3-Year SPYRAL HTN-ON MED Trial
NASDAQ Stock Market
Like Comment
